This content is machine translated Obstructive sleep apnea Healthier heart thanks to CPAP People with obstructive sleep apnea (OSA) have an increased risk of cardiovascular problems, but there is conflicting data regarding the effects of CPAP on reducing this risk. A study now…
View Post 3 min This content is machine translated New ESH guideline Screen hypertensive patients regularly for albuminuria The prevention of hypertension-associated secondary diseases is the focus of the new ESH (European Society of Hypertension ) hypertension guideline. Special emphasis is placed on secondary prevention with regard to…
View Post 9 min This content is machine translated Cardiac resynchronization therapy (CRT) How useful is it to upgrade implantable cardiac devices? Newly implanted cardiac resynchronization therapy with defibrillator (CRT-D) reduces the risk of morbidity and mortality in patients with left bundle branch block, heart failure and reduced ejection fraction (HFrEF). However,…
View Post 14 min This content is machine translated Suspicion of coronary heart disease Stress echocardiography, MR heart or computed tomography heart? The diagnosis of coronary heart disease (CHD) is a major cost driver in the healthcare system, due to the frequency of CHD and the frequent residual uncertainty after a diagnostic… CME-Test
View Post 11 min This content is machine translated Artificial intelligence in medicine Opportunities and risks of AI The concept of artificial intelligence dates back to the 1950s. 20th century and includes a collection of technologies that allow a computer to emulate typical characteristics of human intelligence. Initially,… CME-Test
View Post 10 min This content is machine translated GLP-1 agonists continue to gain ground Semaglutide in patients with obesity and heart failure It has long been known that the active ingredient class of glucagon-like peptide-1 agonists (GLP-1) reduces cardiovascular consequences in diabetics and leads to significant weight loss in patients with obesity.…
View Post 11 min This content is machine translated Artificial intelligence in medicine Opportunities and risks of AI The concept of artificial intelligence dates back to the 1950s. 20th century and includes a collection of technologies that allow a computer to emulate typical characteristics of human intelligence. Initially,… CME-Test
View Post 4 min This content is machine translated SGLT-2-i in type 2 diabetes and CVD Cardioprotective mechanisms of action of empagliflozin – what’s new? Empagliflozin is known to reduce the risk of atherosclerotic cardiovascular disease (CVD) in people with type 2 diabetes and high cardiovascular risk. The mechanisms underlying these effects are not yet…
View Post 14 min This content is machine translated Suspicion of coronary heart disease Stress echocardiography, MR heart or computed tomography heart? The diagnosis of coronary heart disease (CHD) is a major cost driver in the healthcare system, due to the frequency of CHD and the frequent residual uncertainty after a diagnostic… CME-Test
View Post 6 min This content is machine translated Coronary heart disease and type 2 diabetes Relationship between baseline FFA values and all-cause mortality. It is known that elevated levels of free fatty acids (FFA) are strongly associated with all-cause mortality in patients with coronary heart disease (CHD) and the development of type 2…
View Post 10 min This content is machine translated Pulmonary arterial hypertension beyond the guideline. IPAH or what else? – IPAH with pulmonary comorbidity Pulmonary hypertension is divided into five different groups, with group 1 reflecting pulmonary arterial hypertension (PAH). The PH-specific drug therapies approved to date interfere with three different signaling pathways (NO… CME-Test
